Literature DB >> 9718414

Diagnosis of encephalopathy.

K Weissenborn1.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9718414     DOI： 10.1159/000051415

Source DB:  PubMed          Journal:  Digestion        ISSN： 0012-2823            Impact factor:   3.216


× No keyword cloud information.
  14 in total

1.  Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study.

Authors:  Vijay P B Grover; Mary M E Crossey; Julie A Fitzpatrick; Brian K Saxby; Roberta Shaw; Adam D Waldman; Marsha Y Morgan; Simon D Taylor-Robinson
Journal:  Metab Brain Dis       Date:  2015-08-08       Impact factor: 3.584

Review 2.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 3.  MR imaging findings in hepatic encephalopathy.

Authors:  A Rovira; J Alonso; J Córdoba
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

4.  Liver transplantation nearly normalizes brain spontaneous activity and cognitive function at 1 month: a resting-state functional MRI study.

Authors:  Yue Cheng; Lixiang Huang; Xiaodong Zhang; Jianhui Zhong; Qian Ji; Shuangshuang Xie; Lihua Chen; Panli Zuo; Long Jiang Zhang; Wen Shen
Journal:  Metab Brain Dis       Date:  2015-02-24       Impact factor: 3.584

5.  Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.

Authors:  Harry D Zacharias; Antony P Zacharias; Lise Lotte Gluud; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2019-06-17

Review 6.  Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.

Authors:  Lise Lotte Gluud; Hendrik Vilstrup; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2016-05-06

Review 7.  Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.

Authors:  Ee Teng Goh; Mette L Andersen; Marsha Y Morgan; Lise Lotte Gluud
Journal:  Cochrane Database Syst Rev       Date:  2017-07-26

Review 8.  Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.

Authors:  Ee Teng Goh; Mette L Andersen; Marsha Y Morgan; Lise Lotte Gluud
Journal:  Cochrane Database Syst Rev       Date:  2017-08-10

9.  Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.

Authors:  Mariano Malaguarnera; Filippo Greco; Gloria Barone; Maria Pia Gargante; Michele Malaguarnera; Maria Antonietta Toscano
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

Review 10.  L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.

Authors:  Ee Teng Goh; Caroline S Stokes; Sandeep S Sidhu; Hendrik Vilstrup; Lise Lotte Gluud; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2018-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.